Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Safety and Efficacy of Cord Tissue Derived Mesenchymal Stromal Cells (hCT-MSC) in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)

NCT04399889 is registered in ClinicalTrials.gov with Joanne Kurtzberg, MD as lead sponsor.

NCT NCT04399889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04399889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Safety and Efficacy of Cord Tissue Derived Mesenchymal Stromal Cells (hCT-MSC) in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)
Lead sponsor
Joanne Kurtzberg, MD
Phase
Phase 1/2
Overall status
Terminated
Start date
June 18, 2020
Completion date
February 16, 2022
Enrollment
12 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid, covid19